Roche cobas® 6000

Roche cobas® 6000

The cobas 6000 analyzer series delivers an efficient mix of broad test menu and fast turnaround time – even as workloads grow. Most high performing labs stake their reputation on quality. The trust of their clinicians is paramount. The cobas 6000 analyzer series inspires confidence by reaching superior standards of analytical performance.
From routine assays to innovative biomarkers, most high performing labs need easy to use and cost effective reagents. The cobas 6000 analyzer series delivers by offering liquid ready-to-use reagents based on a unique reagent concept.

Features
• Consolidates more than 150 tests on one integrated platform
• Combines STAT with routine testing without disruption
• Seamlessly integrates pre- and post- analytical solutions
• Flexibility to expand and reconfigure existing system configurations onsite to meet your lab’s evolving needs
• Industry leading 9-minute STAT cardiac assays on a lab based platform
• Liquid ready-to-use cobas c and cobas e packs (95 percent of total assay portfolio) eliminate error involved with human mixing of reagents
• “On the fly” loading of chemistry reagents during operation
• Standardized reagents across the cobas family of analyzers
• Economic usage with high stabilities and convenient kit sizes. Long on-board stability (OBS) of cobas reagents minimizes wasted tests. Immunoassays have an OBS of 56 days and chemistries have OBS of 67 days on average
• State-of-the-art immunoassay tests using electrochemiluminscence (ECL) technology offers a broad measuring range and low end sensitivity (i.e. HCG+β: 0.10 – 10,000 mIU/mL), virtually eliminating the need for dilutions and repeat testing
• Standardized test results between all testing sites using cobas family of analyzers allow for greater consistency in physician result interpretation
• Sample and system integrity checks help to ensure quality results (e.g. test-specific serum indices, disposable immunoassay tips and cups, and clot and liquid level detection)
• ECL immunoassays have CV (co-efficient of variation) of less than six percent on average


technical specification
test menu